These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


145 related items for PubMed ID: 23625134

  • 1. An atypical manifestation of acquired von Willebrand syndrome (AVWS) associated with systemic lupus erythematosus (SLE).
    Kasatkar P, Ghosh K, Shetty S.
    Ann Hematol; 2014 Jan; 93(1):173-5. PubMed ID: 23625134
    [No Abstract] [Full Text] [Related]

  • 2. Acquired von Willebrand syndromes: clinical features, aetiology, pathophysiology, classification and management.
    Michiels JJ, Budde U, van der Planken M, van Vliet HH, Schroyens W, Berneman Z.
    Best Pract Res Clin Haematol; 2001 Jun; 14(2):401-36. PubMed ID: 11686107
    [Abstract] [Full Text] [Related]

  • 3. Systemic lupus erythematosus complicated by acquired von Willebrand's syndrome.
    Hong S, Lee J, Chi H, Lee C, Nah S, Kim Y, Oh J, Moon H, Yoo B.
    Lupus; 2008 Sep; 17(9):846-8. PubMed ID: 18755868
    [Abstract] [Full Text] [Related]

  • 4. Three cases of acquired von Willebrand disease associated with systemic lupus erythematosus.
    Viallard JF, Pellegrin JL, Vergnes C, Borel-Derlon A, Clofent-Sanchez G, Nurden AT, Leng B, Nurden P.
    Br J Haematol; 1999 May; 105(2):532-7. PubMed ID: 10233433
    [Abstract] [Full Text] [Related]

  • 5. Rituximab effectiveness in a patient with juvenile systemic lupus erythematosus complicated with acquired Von Willebrand syndrome.
    Jimenez AR, Vallejo ES, Cruz MZ, Cruz AC, Miramontes JV, Jara BS.
    Lupus; 2013 Dec; 22(14):1514-7. PubMed ID: 23989733
    [Abstract] [Full Text] [Related]

  • 6. Puerperal acquired factor VIII inhibitor causing a von Willebrand-like syndrome in a patient with anti-DNA antibodies.
    Jackson N, Hashim ZA, Zainal NA, Jamaluddin N.
    Singapore Med J; 1995 Apr; 36(2):230-1. PubMed ID: 7676276
    [Abstract] [Full Text] [Related]

  • 7. [Diagnosis of Von Willebrand's syndrome (author's transl)].
    Hariga-Muller C, Capel P, De Maertelaere-Laurent E, Masramon AM, Fondu P.
    Rev Med Brux; 1981 Mar; 2(3):245-50. PubMed ID: 6785854
    [No Abstract] [Full Text] [Related]

  • 8. Diagnosis and therapeutic management in a patient with type 2B-like acquired von Willebrand syndrome.
    Karger R, Weippert-Kretschmer M, Budde U, Kretschmer V.
    Blood Coagul Fibrinolysis; 2011 Mar; 22(2):144-7. PubMed ID: 21178586
    [Abstract] [Full Text] [Related]

  • 9. The von Willebrand syndrome.
    Bloom AL.
    Semin Hematol; 1980 Oct; 17(4):215-27. PubMed ID: 6160617
    [No Abstract] [Full Text] [Related]

  • 10. Acquired von Willebrand syndrome in systemic lupus erythematodes.
    Michiels JJ, Schroyens W, van der Planken M, Berneman Z.
    Clin Appl Thromb Hemost; 2001 Apr; 7(2):106-12. PubMed ID: 11292186
    [Abstract] [Full Text] [Related]

  • 11. [Participation of von Willebrand factor in blood platelet functions].
    Mikami S, Takahashi Y, Nishino M, Fukui H.
    Nihon Rinsho; 1978 Dec 10; 36(12):3824-9. PubMed ID: 372620
    [No Abstract] [Full Text] [Related]

  • 12. Acquired von Willebrand syndrome: a rare disorder of heterogeneous etiology.
    Kasatkar P, Ghosh K, Shetty S.
    J Postgrad Med; 2013 Dec 10; 59(2):98-101. PubMed ID: 23793308
    [Abstract] [Full Text] [Related]

  • 13. Heterogeneity in von Willebrand's disease.
    Ruggeri ZM, Zimmerman TS.
    Prog Clin Biol Res; 1981 Dec 10; 72():139-48. PubMed ID: 6801683
    [No Abstract] [Full Text] [Related]

  • 14. Thrombosis in systemic lupus erythematosus. Relation to the presence of circulating anticoagulants.
    Glueck HI, Kant KS, Weiss MA, Pollak VE, Miller MA, Coots M.
    Arch Intern Med; 1985 Aug 10; 145(8):1389-95. PubMed ID: 3927865
    [Abstract] [Full Text] [Related]

  • 15. Immune-mediated etiology of acquired von Willebrand syndrome in systemic lupus erythematosus and in benign monoclonal gammopathy: therapeutic implications.
    Michiels JJ, Berneman Z, Gadisseur A, van der Planken M, Schroyens W, Budde U, van Vliet HH.
    Semin Thromb Hemost; 2006 Sep 10; 32(6):577-88. PubMed ID: 16977568
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Platelet factor 3 availability test: an effective screening test for types 1 and 2 von Willebrand disease.
    Gupta PK, Ahmed R, Kannan M, Chatterjee T, Choudhry VP, Saxena R.
    Ann Hematol; 2004 Jul 10; 83(7):489-90. PubMed ID: 15052373
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.